Treatment for Ringworm (Dermatophytosis)
The treatment of ringworm depends critically on the location of infection: scalp ringworm (tinea capitis) requires oral antifungal therapy, while body/groin/foot ringworm (tinea corporis/cruris/pedis) can typically be treated with topical antifungals alone.
Scalp Ringworm (Tinea Capitis)
First-Line Oral Therapy
Topical therapy alone is NOT effective for scalp ringworm—oral antifungal medication is mandatory 1. The choice between griseofulvin and terbinafine depends on the causative organism:
For Trichophyton species (T. tonsurans, T. violaceum, T. soudanense):
- Terbinafine is more effective 1
- <20 kg: 62.5 mg daily for 2-4 weeks
- 20-40 kg: 125 mg daily for 2-4 weeks
40 kg: 250 mg daily for 2-4 weeks
For Microsporum species (M. canis, M. audouinii):
- Griseofulvin is more effective 1
- <50 kg: 15-20 mg/kg daily for 6-8 weeks
50 kg: 1 g daily for 6-8 weeks
- Take with fatty food to improve absorption 1
Key advantage of terbinafine: Shorter treatment duration (2-4 weeks vs 6-8 weeks), which improves compliance 1. However, griseofulvin remains the only licensed treatment for tinea capitis in children in the UK 1.
Second-Line Therapy
If first-line treatment fails, use itraconazole 5 mg/kg daily or 50-100 mg daily for 4 weeks 1. Itraconazole has activity against both Trichophyton and Microsporum species.
Treatment Failure Management
Before switching medications, consider 1:
- Poor compliance
- Suboptimal drug absorption
- Reinfection from untreated family members
- If clinical improvement but positive cultures persist: continue current therapy 2-4 more weeks
- If no clinical improvement: switch to second-line therapy
Critical Additional Measures
Family screening is mandatory for T. tonsurans infections—over 50% of family members may be infected, often asymptomatically 1. Treat all positive cases to prevent recurrence.
Adjunctive topical therapy: Use antifungal shampoos (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission 1.
Follow-up: The endpoint is mycological cure, not just clinical improvement. Repeat cultures until clearance is achieved 1.
School attendance: Children on appropriate therapy can attend school 1.
Body, Groin, and Foot Ringworm (Tinea Corporis/Cruris/Pedis)
First-Line Topical Therapy
For non-scalp dermatophytosis, topical antifungals are typically sufficient 2:
- Terbinafine cream
- Clotrimazole cream
- Miconazole cream
Apply to affected area and 2-3 cm beyond the visible border, typically for 2-4 weeks.
When to Use Oral Therapy
Consider oral antifungals for:
- Extensive or widespread infection
- Failed topical therapy
- Immunocompromised patients
- Nail involvement (onychomycosis)
Emerging Resistance Concerns
Important caveat: Recent evidence shows emerging terbinafine-resistant dermatophytes, particularly Trichophyton indotineae and resistant T. rubrum strains 3, 4. If treatment fails despite good compliance:
- Consider fungal culture with antifungal susceptibility testing
- Itraconazole may be preferred over terbinafine in recalcitrant cases 3
- Avoid empiric corticosteroid use, which can worsen infection 3
Critical Pitfalls to Avoid
Never use topical corticosteroid-antifungal combinations long-term (>2 weeks for tinea cruris, >4 weeks for tinea pedis/corporis) 5. While they may provide initial symptom relief, corticosteroids can:
- Suppress local immunity and allow deeper fungal invasion
- Mask infection progression
- Cause cutaneous adverse effects, especially in children
Never use corticosteroids alone or in combination for:
- Children <12 years
- Facial lesions
- Diaper areas
- Immunosuppressed patients 5
Do not assume treatment failure means resistance—first verify compliance, adequate dosing, and rule out reinfection 1.
For scalp infections, do not rely on clinical appearance alone—obtain fungal culture when possible to guide species-specific therapy 1.